Immunotherapy for Cancer Patients | Max Hospital
/blogs/cancer-care-oncology-radiation-oncology/immunotherapy-cancer-patientsawdawdadadw
  1. Home
  2. Blogs
  3. Cancer Care Oncology Radiation Oncology
  4. Immunotherapy for Cancer Patients

Get Second Opinion

Please provide your phone number with country code

10 + 3 =

Doc Connect

Hospital : 
Max Super Speciality Hospital, Saket
Description: 
  • Robotic Urological Surgery: 15 years journey 
    Dr. Rahul Yadav, Dr. Anant Kumar
  • Robotic surgery is the latest in advanced onco surgical procedures 
    Dr. Harit Chaturvedi
  • Percutaneous balloon aortic valvuloplasty & balloon dilatation of aortic coarctation in a 10 year old child 
    Dr. Neeraj Awasthy, Dr. Sushil Shukla
  • Role of CT/MR imaging and echocardiography in evaluation of valsalva sinus aneurysm 
    Dr. Reena Anand, Dr. Raj Kumar, Dr. Divya Malhotra, Dr. Bharat Aggarwal
  • Risk factors for patients undergoing treatment for Breast Cancer
    Ms. Kanika Arora, Ms. Ritika Samaddar
  • Radiology Case of The Month 
    Dr. Nafisa Shakir Batta, Dr. Dhruv Jain
Date: 
October, 2015 :15
Emergency Call Button

DELHI / NCR : 011-4055 4055

MOHALI : 77107-77107

DEHRADUN : 0135 719 3333

BATHINDA : +91 0164-5212000

 

Bio Medical Waste Report For Shalimar Bagh

Month Red Autoclave(Infected Plastic Waste) Yellow- Incineration(AnatomicalWaste & Soiled Waste) Blue Autoclave (Glass- Bottles) Black Cytotoxic- Incineration( Cytotoxic Contaminated Items) White- Sharp Total Bags Total Weight(In KG's)
  No. of Bags Weight (in KG's) No. of Bags Weight (in KG's) No. of Bags Weight (in KG's) No. of Bags Weight (in KG's) No. of Bags Weight (in KG's)    
Apr-17 924 2963.50 954 2994.10 239 1017.30 103 279.20 1645 606.40 3865 7861.00
May-17 1175 4624.12 1028 3498.40 276 1524.34 87 195.01 1803 823.85 4369 10665.71
Jun-17 1060 4511.45 902 2886.66 293 1324.05 76 194.00 2057 1100.69 4388 10016.85
Jul-17                     0 0.00
Aug-17                     0 0.00
Sep-17                     0 0.00
Oct-17                     0 0.00
Nov-17                     0 0.00
Dec-17                     0 0.00
Jan-18                     0 0.00
Feb-18                     0 0.00
Mar-18                     0 0.00
YTD 3159 12099.065 2884 9379.155 808 3865.69 266 668.705 5505 2530.94 12622 28543.555

Immunotherapy for Cancer Patients

Home >> Blogs >> Cancer Care Oncology Radiation Oncology >> Immunotherapy for Cancer Patients

Clinical Directorate

For more info please call 8744 888 888 (Delhi – NCR) & 9988 422 333 (Chandigarh Tri-city), or mail at homecare@maxhealthcare.com

October 21, 2019 0 2 minutes, 54 seconds read
Cancer Care / Oncology, Gastrointestinal Oncology, Hematology Oncology, Musculoskeletal Oncology, Medical Oncology, Neuro Oncology, Pediatrics/Paediatric Oncology, Thoracic Oncology, Urology Oncology

When it comes to lung cancer, there is a disparity in gains that research is bringing to us. In some of the diseases we are desperately searching for alternative therapies but so far, we are far from finding new solutions. In lung cancer, immunotherapy offers us hope. Our aim is not only to control the disease process but also offer potential cure to such patients or make it a chronic disease.

Lung cancer continues to be an aggressive disease worldwide and is one of the leading causes of deaths all around the world. The advent of immunotherapy brings us new hope.

One begins to wonder how does it work to bring such amazing results and how can we utilize it to its maximum potential. Immunotherapy uses body’s own immune system. It activates the immune system by activating immune cells that have been put to sleep by cancer cells. There are different ways of doing it. But most common is by immune check point inhibitors (for example Nivolumab, Pembrolizumab and Atezolizumab). These drugs have revolutionized the treatment of lung cancer and now first time in my career I have seen such patients surviving beyond 3 years.

Since chemotherapy can offer only a limited amount of help in fighting lung cancer, a growing emphasis on prevention, as well as on the development of immunotherapy will be extremely important here in India over the next couple of years. We will continue our research in this field.

A 60 year old male patient, ex serviceman presented to us in 2016 .He was diagnosed in 2015 and his cancer was progressing after 2 lines of chemotherapy. Examination revealed fluid around his heart along with an extremely poor lung function. He was referred to cardiologist who removed the fluid from around his heart. Coincidentally in the same year immunotherapy also got approved in India for lung cancer treatment. He was started on Nivolumab and after receiving 4 cycles of nivolumab he started responding to the drug. Can you guess the response? You guessed it right. It’s been 3 years since he was started on nivolumab and the response has been extremely good so far. On comparison to a 6-12 month survival with chemotherapy in a patient with an aggressive biology lung cancer, this seems to be magic and almost impossible. Although every patient may not respond the same way, this definitely gives us a strong reason to have more aggressive research on immunotherapy.

This response was not just seen with one patient. With the passage of time, we have come across many such long term survivors, plenty enough to dig deeper in the understanding of immunotherapy.

Most lung cancer patients become symptomatic and are diagnosed, only when the disease has advanced to a late stage (at stage IIIb/IV or higher). This is another major issue usually faced with lung cancer patients. At such a stage we are left with minimal options. With surgery, chemotherapy and radiation being minimally effective in advanced lung cancer patients, we are stuck in a difficult spot. Therefore, new and more effective, long-lasting treatments are needed for patients facing such a challenge. Hence it makes lung cancer one of the major cancer types for which, new immune-based cancer treatments are making an impact on the survival of such patients.

Here is a small drawing I made to make it easier for you to understand.

For better understanding or if you want to know more contact Dr Waseem Abbas. I, being a keen researcher would welcome thoughts and doubts.

Related Articles

Featured Doctors

Book an Appointment